Fig 1: Protein analysis of bilateral and unilateral injured TAs, with or without, MMG treatment.Quantification of protein levels using ELISAs at 8 weeks post-VML injury for A alpha smooth muscle actin (ACTA2), B collagen type 1 alpha 1 (COL1A1), C transforming growth factor beta (TGFß), D insulin-like growth factor (IGF), E myosin heavy chain 3 (MYH3), F PAX7, and G myogenin (MGN). Data is presented as mean ± SEM.
Fig 2: Transcriptional analysis of bilateral and unilateral injured TAs, with or without, MMG treatment.Quantification of transcription levels by RT-qPCR at 8 weeks post-VML injury for A alpha smooth muscle actin (Acta2), B collagen type 1 alpha 1 (Col1a1), C transforming growth factor beta (Tgfb), D insulin-like growth factor (Igf1), E myosin heavy chain 3 (Myh3), F Pax7, G myogenin (Myog), and H myoblast determination protein 1 (MyoD). Data is presented as mean ± SEM. * = P < 0.05.
Supplier Page from MyBioSource.com for Rat Myosin Heavy Chain 3, Skeletal Muscle, Embryonic ELISA Kit